Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-03

AUTHORS

Ken Overturf, Muhsen Al-Dhalimy, Robert Tanguay, Mark Brantly, Ching-Nan Ou, Milton Finegold, Markus Grompe

ABSTRACT

Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer More... »

PAGES

266-273

Journal

TITLE

Nature Genetics

ISSUE

3

VOLUME

12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ng0396-266

DOI

http://dx.doi.org/10.1038/ng0396-266

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043996615

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8589717


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Metabolism, Inborn Errors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclohexanones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrolases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoenzyme Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrobenzoates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retroviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tyrosine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA", 
          "id": "http://www.grid.ac/institutes/grid.5288.7", 
          "name": [
            "Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Overturf", 
        "givenName": "Ken", 
        "id": "sg:person.012474421634.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012474421634.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA", 
          "id": "http://www.grid.ac/institutes/grid.5288.7", 
          "name": [
            "Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al-Dhalimy", 
        "givenName": "Muhsen", 
        "id": "sg:person.015321277547.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015321277547.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire de g\u00e9n\u00e9tique cellulaire et developementale, Universit\u00e9 Laval, G1K7P4, Ste-Foy, Qu\u00e9bec, Canada", 
          "id": "http://www.grid.ac/institutes/grid.23856.3a", 
          "name": [
            "Laboratoire de g\u00e9n\u00e9tique cellulaire et developementale, Universit\u00e9 Laval, G1K7P4, Ste-Foy, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanguay", 
        "givenName": "Robert", 
        "id": "sg:person.0575671026.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575671026.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pulmonary-Critical Care Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, 20892\u20131590, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.279885.9", 
          "name": [
            "Pulmonary-Critical Care Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, 20892\u20131590, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brantly", 
        "givenName": "Mark", 
        "id": "sg:person.01034511403.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034511403.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.416975.8", 
          "name": [
            "Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ou", 
        "givenName": "Ching-Nan", 
        "id": "sg:person.012541531512.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012541531512.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.416975.8", 
          "name": [
            "Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Finegold", 
        "givenName": "Milton", 
        "id": "sg:person.014103516477.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014103516477.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Oregon Health Sciences University, 97201, Portland, Oregon, USA", 
          "id": "http://www.grid.ac/institutes/grid.5288.7", 
          "name": [
            "Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA", 
            "Department of Pediatrics, Oregon Health Sciences University, 97201, Portland, Oregon, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grompe", 
        "givenName": "Markus", 
        "id": "sg:person.01126164604.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126164604.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ng0895-453", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044553748", 
          "https://doi.org/10.1038/ng0895-453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0494-335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016499584", 
          "https://doi.org/10.1038/ng0494-335"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-76015-0_9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018578317", 
          "https://doi.org/10.1007/978-3-642-76015-0_9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/197452a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050179231", 
          "https://doi.org/10.1038/197452a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02034752", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000225604", 
          "https://doi.org/10.1007/bf02034752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/346245a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045781048", 
          "https://doi.org/10.1038/346245a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1996-03", 
    "datePublishedReg": "1996-03-01", 
    "description": "Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ng0396-266", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2495263", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1103138", 
        "issn": [
          "1061-4036", 
          "1546-1718"
        ], 
        "name": "Nature Genetics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "hepatic gene therapy", 
      "gene therapy", 
      "permanent gene expression", 
      "liver gene transfer", 
      "gene transfer", 
      "retroviral gene transfer", 
      "vivo selection", 
      "fumarylacetoacetate hydrolase", 
      "retrovirus injection", 
      "tyrosinaemia type I", 
      "hereditary tyrosinaemia type I", 
      "current strategies", 
      "useful strategy", 
      "situ", 
      "efficiency", 
      "transfer", 
      "competitive growth advantage", 
      "mutant liver", 
      "advantages", 
      "strategies", 
      "mutant hepatocytes", 
      "hydrolase", 
      "vivo", 
      "selection", 
      "gene expression", 
      "hepatocytes", 
      "therapy", 
      "wild-type hepatocytes", 
      "results", 
      "growth advantage", 
      "animal models", 
      "type I", 
      "expression", 
      "effective treatment", 
      "injection", 
      "function", 
      "HT1", 
      "mutant animals", 
      "murine model", 
      "model", 
      "lack", 
      "treatment", 
      "liver", 
      "deficiency", 
      "animals", 
      "disease", 
      "liver function", 
      "liver disease"
    ], 
    "name": "Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I", 
    "pagination": "266-273", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043996615"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ng0396-266"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8589717"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ng0396-266", 
      "https://app.dimensions.ai/details/publication/pub.1043996615"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_269.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ng0396-266"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ng0396-266'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ng0396-266'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ng0396-266'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ng0396-266'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      100 URIs      86 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ng0396-266 schema:about N51ab2c0c8ab4437dbf72539759e927c1
2 N5f158d3f847c4331b1e67fccd99619f0
3 N6a367f36f9a84cf3a533f4e73f6f4abc
4 N6eec6ed02afd4d7f80d0141583ddaa24
5 N73c3cf86354a4eacaa7de195da37716e
6 N795c8dc2159f4262ac2fd506b9c09caf
7 N89d4b0e9c7cb4df5ad288606ad11c53d
8 N9b6eb6ed341e4fecb0addbdfcc56509c
9 Nb560f9d324af4df0be65ecc572d5110a
10 Nb649e753898f44f0bc31f25558e043a4
11 Nbc22a1eab4b94997803c3529dabf741a
12 Nc2a6446bc65c420d951306a5bf04ad8a
13 Nd49cc13eb089454abacc7d6c3bd0c320
14 Ndcf524f64fa74911ba31f3e51cee9f7c
15 Ne879bd568b854abaa020ff05384cb47b
16 Ne90dbc66b4eb4961805e5f04b468b982
17 Nf147e594ebe24580861874b2e79b0368
18 Nf257e2edf7034879a66869321ffc538c
19 Nf47533e833c2423d8cc427d50afabce8
20 Nfd3d164b41e04b058b28f09a86fa5770
21 anzsrc-for:06
22 anzsrc-for:11
23 schema:author N781a37fffe6745e5a9cea496adff301b
24 schema:citation sg:pub.10.1007/978-3-642-76015-0_9
25 sg:pub.10.1007/bf02034752
26 sg:pub.10.1038/197452a0
27 sg:pub.10.1038/346245a0
28 sg:pub.10.1038/ng0494-335
29 sg:pub.10.1038/ng0895-453
30 schema:datePublished 1996-03
31 schema:datePublishedReg 1996-03-01
32 schema:description Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer
33 schema:genre article
34 schema:isAccessibleForFree false
35 schema:isPartOf N5b75bf08268a4eb5bba1d3ceb45f815e
36 N6e93bb589f554e85bf4f9efcdcc0b4c6
37 sg:journal.1103138
38 schema:keywords HT1
39 advantages
40 animal models
41 animals
42 competitive growth advantage
43 current strategies
44 deficiency
45 disease
46 effective treatment
47 efficiency
48 expression
49 fumarylacetoacetate hydrolase
50 function
51 gene expression
52 gene therapy
53 gene transfer
54 growth advantage
55 hepatic gene therapy
56 hepatocytes
57 hereditary tyrosinaemia type I
58 hydrolase
59 injection
60 lack
61 liver
62 liver disease
63 liver function
64 liver gene transfer
65 model
66 murine model
67 mutant animals
68 mutant hepatocytes
69 mutant liver
70 permanent gene expression
71 results
72 retroviral gene transfer
73 retrovirus injection
74 selection
75 situ
76 strategies
77 therapy
78 transfer
79 treatment
80 type I
81 tyrosinaemia type I
82 useful strategy
83 vivo
84 vivo selection
85 wild-type hepatocytes
86 schema:name Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
87 schema:pagination 266-273
88 schema:productId N3b445ddc3a57455291688a95e898d630
89 N4695aac324d145f89e1a65f4204aec01
90 Ne2ee197397f24ca6b9de3d6422fc92b2
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043996615
92 https://doi.org/10.1038/ng0396-266
93 schema:sdDatePublished 2022-09-02T15:47
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N1668670c0d7e427c86546614f4592ea4
96 schema:url https://doi.org/10.1038/ng0396-266
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N1668670c0d7e427c86546614f4592ea4 schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N3b445ddc3a57455291688a95e898d630 schema:name doi
103 schema:value 10.1038/ng0396-266
104 rdf:type schema:PropertyValue
105 N436c2c019a504ba4bb62e62ee8d61bd8 rdf:first sg:person.015321277547.53
106 rdf:rest Nddeed88131a74c19bea1df11087005b6
107 N4695aac324d145f89e1a65f4204aec01 schema:name pubmed_id
108 schema:value 8589717
109 rdf:type schema:PropertyValue
110 N51ab2c0c8ab4437dbf72539759e927c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Male
112 rdf:type schema:DefinedTerm
113 N5b75bf08268a4eb5bba1d3ceb45f815e schema:issueNumber 3
114 rdf:type schema:PublicationIssue
115 N5f158d3f847c4331b1e67fccd99619f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Immunoenzyme Techniques
117 rdf:type schema:DefinedTerm
118 N6a367f36f9a84cf3a533f4e73f6f4abc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Tyrosine
120 rdf:type schema:DefinedTerm
121 N6e93bb589f554e85bf4f9efcdcc0b4c6 schema:volumeNumber 12
122 rdf:type schema:PublicationVolume
123 N6eec6ed02afd4d7f80d0141583ddaa24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Disease Models, Animal
125 rdf:type schema:DefinedTerm
126 N73407571362e4a389efa926af920254f rdf:first sg:person.014103516477.24
127 rdf:rest Nc1ead7d17fc3481db2a3662dc1effcb0
128 N73c3cf86354a4eacaa7de195da37716e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Cell Transplantation
130 rdf:type schema:DefinedTerm
131 N781a37fffe6745e5a9cea496adff301b rdf:first sg:person.012474421634.40
132 rdf:rest N436c2c019a504ba4bb62e62ee8d61bd8
133 N795c8dc2159f4262ac2fd506b9c09caf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Cell Count
135 rdf:type schema:DefinedTerm
136 N89d4b0e9c7cb4df5ad288606ad11c53d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Amino Acid Metabolism, Inborn Errors
138 rdf:type schema:DefinedTerm
139 N9a362fbe04e444a0b670f78c1fb932cd rdf:first sg:person.01034511403.30
140 rdf:rest Ndb2bd13c94604d5b90199af0791b580f
141 N9b6eb6ed341e4fecb0addbdfcc56509c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Mice, Inbred C57BL
143 rdf:type schema:DefinedTerm
144 Nb560f9d324af4df0be65ecc572d5110a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Nitrobenzoates
146 rdf:type schema:DefinedTerm
147 Nb649e753898f44f0bc31f25558e043a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Hydrolases
149 rdf:type schema:DefinedTerm
150 Nbc22a1eab4b94997803c3529dabf741a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Retroviridae
152 rdf:type schema:DefinedTerm
153 Nc1ead7d17fc3481db2a3662dc1effcb0 rdf:first sg:person.01126164604.61
154 rdf:rest rdf:nil
155 Nc2a6446bc65c420d951306a5bf04ad8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Liver Neoplasms
157 rdf:type schema:DefinedTerm
158 Nd49cc13eb089454abacc7d6c3bd0c320 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Liver Function Tests
160 rdf:type schema:DefinedTerm
161 Ndb2bd13c94604d5b90199af0791b580f rdf:first sg:person.012541531512.12
162 rdf:rest N73407571362e4a389efa926af920254f
163 Ndcf524f64fa74911ba31f3e51cee9f7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Cyclohexanones
165 rdf:type schema:DefinedTerm
166 Nddeed88131a74c19bea1df11087005b6 rdf:first sg:person.0575671026.25
167 rdf:rest N9a362fbe04e444a0b670f78c1fb932cd
168 Ne2ee197397f24ca6b9de3d6422fc92b2 schema:name dimensions_id
169 schema:value pub.1043996615
170 rdf:type schema:PropertyValue
171 Ne879bd568b854abaa020ff05384cb47b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Genetic Therapy
173 rdf:type schema:DefinedTerm
174 Ne90dbc66b4eb4961805e5f04b468b982 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Animals
176 rdf:type schema:DefinedTerm
177 Nf147e594ebe24580861874b2e79b0368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Mice
179 rdf:type schema:DefinedTerm
180 Nf257e2edf7034879a66869321ffc538c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Humans
182 rdf:type schema:DefinedTerm
183 Nf47533e833c2423d8cc427d50afabce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Enzyme Inhibitors
185 rdf:type schema:DefinedTerm
186 Nfd3d164b41e04b058b28f09a86fa5770 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Liver
188 rdf:type schema:DefinedTerm
189 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
190 schema:name Biological Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 sg:grant.2495263 http://pending.schema.org/fundedItem sg:pub.10.1038/ng0396-266
196 rdf:type schema:MonetaryGrant
197 sg:journal.1103138 schema:issn 1061-4036
198 1546-1718
199 schema:name Nature Genetics
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01034511403.30 schema:affiliation grid-institutes:grid.279885.9
203 schema:familyName Brantly
204 schema:givenName Mark
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034511403.30
206 rdf:type schema:Person
207 sg:person.01126164604.61 schema:affiliation grid-institutes:grid.5288.7
208 schema:familyName Grompe
209 schema:givenName Markus
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126164604.61
211 rdf:type schema:Person
212 sg:person.012474421634.40 schema:affiliation grid-institutes:grid.5288.7
213 schema:familyName Overturf
214 schema:givenName Ken
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012474421634.40
216 rdf:type schema:Person
217 sg:person.012541531512.12 schema:affiliation grid-institutes:grid.416975.8
218 schema:familyName Ou
219 schema:givenName Ching-Nan
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012541531512.12
221 rdf:type schema:Person
222 sg:person.014103516477.24 schema:affiliation grid-institutes:grid.416975.8
223 schema:familyName Finegold
224 schema:givenName Milton
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014103516477.24
226 rdf:type schema:Person
227 sg:person.015321277547.53 schema:affiliation grid-institutes:grid.5288.7
228 schema:familyName Al-Dhalimy
229 schema:givenName Muhsen
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015321277547.53
231 rdf:type schema:Person
232 sg:person.0575671026.25 schema:affiliation grid-institutes:grid.23856.3a
233 schema:familyName Tanguay
234 schema:givenName Robert
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575671026.25
236 rdf:type schema:Person
237 sg:pub.10.1007/978-3-642-76015-0_9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018578317
238 https://doi.org/10.1007/978-3-642-76015-0_9
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/bf02034752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000225604
241 https://doi.org/10.1007/bf02034752
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/197452a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050179231
244 https://doi.org/10.1038/197452a0
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/346245a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045781048
247 https://doi.org/10.1038/346245a0
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/ng0494-335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016499584
250 https://doi.org/10.1038/ng0494-335
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/ng0895-453 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044553748
253 https://doi.org/10.1038/ng0895-453
254 rdf:type schema:CreativeWork
255 grid-institutes:grid.23856.3a schema:alternateName Laboratoire de génétique cellulaire et developementale, Université Laval, G1K7P4, Ste-Foy, Québec, Canada
256 schema:name Laboratoire de génétique cellulaire et developementale, Université Laval, G1K7P4, Ste-Foy, Québec, Canada
257 rdf:type schema:Organization
258 grid-institutes:grid.279885.9 schema:alternateName Pulmonary-Critical Care Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, 20892–1590, Bethesda, Maryland, USA
259 schema:name Pulmonary-Critical Care Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, 20892–1590, Bethesda, Maryland, USA
260 rdf:type schema:Organization
261 grid-institutes:grid.416975.8 schema:alternateName Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA
262 schema:name Department of Pathology, Texas Children's Hospital, 77030, Houston, Texas, USA
263 rdf:type schema:Organization
264 grid-institutes:grid.5288.7 schema:alternateName Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA
265 Department of Pediatrics, Oregon Health Sciences University, 97201, Portland, Oregon, USA
266 schema:name Department of Molecular and Medical Genetics and Oregon Health Sciences University, 97201, Portland, Oregon, USA
267 Department of Pediatrics, Oregon Health Sciences University, 97201, Portland, Oregon, USA
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...